Notes for P&L

Acquisitions 2025

During 2025, AddLife gained control of all shares in the companies presented in the table below. No individual acquisition is material in terms of net sales and number of employees, and the acquisitions are therefore presented together in the table Net assets of acquired companies at the acquisition date.

Effects of acquisitions

The impact of the acquisitions completed in 2025 on the Group’s assets and liabilities is presented below. The purchase price allocations are preliminary as the fair value has not yet been determined for all items.

Acquired companies

The purchase price allocations are preliminary as the net assets of the acquired companies have not yet been finally analyzed. For this year’s acquisition, the purchase considerations have exceeded the carrying amounts of the net assets in the acquired companies, resulting in the recognition of intangible assets in the purchase price allocations.

The purchase price for this year's acquisition amounts to SEK 331 million (131), whereof SEK 206 million (75) was allocated to goodwill and SEK 78 million (56) to other intangible assets. The consideration consists of cash payment and contingent consideration. 

Contingent consideration

The outcome of contingent considerations depends on the results achieved in the companies and has a set maximum level. At the acquisition date for the acquisition made during the financial year, contingent consideration was measured at fair value and amounted to SEK 74 million which is approximately 55 percent of the maximum outcome. For historical acquisitions where the purchase price has not yet been paid, the estimated fair value of contingent considerations at the end of the reporting period amounts to SEK 51 million, which constitutes 82 percent of the maximum outcome.

Contingent considerations from acquisitions in previous years have been paid out during the financial year in the amount of SEK 51 million, relating to DACH Medical, BonsaiLab, and Emmat Medical.

Holdback

Part of the purchase price withheld by the buyer as security for potential claims against the seller, will be paid to the seller according to the agreed payment plan. The withheld parts of the purchase price are independent of conditions linked to the future performance of the acquired companies.

Goodwill

The goodwill arising from the acquisition is attributable to the expectation that the Group’s position in the relevant market will be strengthened, as well as the expertise developed in the acquired companies.

Net assets of acquired companies at the acquisition date

Intangible non‑current assets

The amounts allocated to intangible assets, such as supplier relationships, customer relationships and technology, were assessed at the discounted value of future cash flows. The amortisation period is determined by estimating the annual decrease in sales attributable to each asset.

Supplier and customer relationships are generally amortised over a period of 10 years and technology over a period of 5–15 years. The goodwill that arose in connection with the acquisitions relate to the Group's position in the current market for each acquisition which is expected to be strengthened and to the knowledge gained in the acquired companies.

Transaction costs

Transaction costs for acquisitions completed during the financial year amounted to SEK 9 million (2) and are recognised in selling expenses.

Effect of acquisitions made in 2025

The acquisition completed during the year have, from the acquisition date, in total affected the Group’s net sales by SEK 65 million (57) and EBITA by SEK 15 million (12).

If the companies acquired in 2025 had been consolidated as from 1 January 2025, they would have been estimated to affect the Group’s net sales and EBITA by SEK 149 million (111) and SEK 27 million (23), respectively.

Finalisation of purchase price allocations 2024

The purchase price allocation for the companies acquired up to and including December 2024 has now been finalised. No material adjustments have been made to the calculations.